QuidelOrtho Corp (QDEL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US2197981051
QuidelOrtho Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.73 bn USD |
| Gross profit | 1.27 bn USD |
| Operating income | -919.20 m USD |
| EBIT | -930.10 m USD |
| Net income | -1.13 bn USD |
| Diluted EPS – continuing operations | -16.69 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About QuidelOrtho Corp
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
More stocks
- Jsti Group (300284.SZ)
- Polar Capital Global Financials Trust PLC (PCFT.L)
- Morgan Advanced Materials PLC (MGAM.L)
- Huaku Development Co Ltd (2548.TW)
- Sinclair, Inc. (SBGI)
- Altri SGPS SA (ALTR.LS)
- COMPASS MINERALS INTERNATIONAL INC (CMP)
- Renta 4 Banco SA (R4.MC)
- JYP Entertainment Corporation (035900.KQ)
- Gui Zhou Tyre Co Ltd (000589.SZ)
- Service Stream Ltd (SSM.AX)
- Run Long Construction Co Ltd (1808.TW)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.